MX2024004478A - Sales de r-ketamina y metodos de uso de las mismas. - Google Patents
Sales de r-ketamina y metodos de uso de las mismas.Info
- Publication number
- MX2024004478A MX2024004478A MX2024004478A MX2024004478A MX2024004478A MX 2024004478 A MX2024004478 A MX 2024004478A MX 2024004478 A MX2024004478 A MX 2024004478A MX 2024004478 A MX2024004478 A MX 2024004478A MX 2024004478 A MX2024004478 A MX 2024004478A
- Authority
- MX
- Mexico
- Prior art keywords
- ketamine
- salts
- methods
- salt
- salt forms
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 6
- 229960003299 ketamine Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254878P | 2021-10-12 | 2021-10-12 | |
| PCT/US2022/046412 WO2023064363A1 (en) | 2021-10-12 | 2022-10-12 | R-ketamine salts and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024004478A true MX2024004478A (es) | 2024-07-01 |
Family
ID=84331621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024004478A MX2024004478A (es) | 2021-10-12 | 2022-10-12 | Sales de r-ketamina y metodos de uso de las mismas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240336556A1 (https=) |
| EP (1) | EP4416126A1 (https=) |
| JP (1) | JP2024539623A (https=) |
| CN (1) | CN118647595A (https=) |
| CA (1) | CA3234818A1 (https=) |
| IL (1) | IL312041A (https=) |
| MX (1) | MX2024004478A (https=) |
| WO (1) | WO2023064363A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE056378T2 (hu) | 2013-09-13 | 2022-02-28 | Univ Chiba Nat Univ Corp | R-Ketamin és sójának alkalmazása gyógyszerekként |
| CN119613277A (zh) * | 2023-09-14 | 2025-03-14 | 江苏恩华药业股份有限公司 | 一种(r)-氯胺酮d-酒石酸盐e晶型及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002338680A1 (en) | 2001-09-21 | 2003-04-07 | Solvias Ag | Sealing system with flow channels |
| HUE056378T2 (hu) | 2013-09-13 | 2022-02-28 | Univ Chiba Nat Univ Corp | R-Ketamin és sójának alkalmazása gyógyszerekként |
| US20200405663A1 (en) | 2017-09-27 | 2020-12-31 | National University Corporation Chiba University | R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition functional disorder |
| US11980595B2 (en) | 2018-02-15 | 2024-05-14 | National University Corporation Chiba University | Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases |
| WO2019213551A1 (en) | 2018-05-04 | 2019-11-07 | Perception Neuroscience, Inc. | Methods of treating substance abuse |
| WO2020138491A1 (ja) | 2018-12-27 | 2020-07-02 | 国立大学法人千葉大学 | 神経発達障害の予防または治療剤としてのｒ－ケタミンおよびその誘導体 |
-
2022
- 2022-10-12 IL IL312041A patent/IL312041A/en unknown
- 2022-10-12 EP EP22802347.9A patent/EP4416126A1/en active Pending
- 2022-10-12 JP JP2024522124A patent/JP2024539623A/ja active Pending
- 2022-10-12 MX MX2024004478A patent/MX2024004478A/es unknown
- 2022-10-12 US US18/700,013 patent/US20240336556A1/en active Pending
- 2022-10-12 WO PCT/US2022/046412 patent/WO2023064363A1/en not_active Ceased
- 2022-10-12 CN CN202280081833.8A patent/CN118647595A/zh active Pending
- 2022-10-12 CA CA3234818A patent/CA3234818A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3234818A1 (en) | 2023-04-20 |
| IL312041A (en) | 2024-06-01 |
| EP4416126A1 (en) | 2024-08-21 |
| US20240336556A1 (en) | 2024-10-10 |
| WO2023064363A9 (en) | 2024-02-15 |
| JP2024539623A (ja) | 2024-10-29 |
| WO2023064363A1 (en) | 2023-04-20 |
| CN118647595A (zh) | 2024-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025011899A (es) | Compuestos de pirido[4,3-d]pirimidina | |
| GEP20237561B (en) | Protein tyrosine phosphatase inhibitors | |
| CR20210602A (es) | Compuestos de pirrolidina | |
| MX2021006265A (es) | Derivados de panteteina y usos de los mismos. | |
| MX2024004478A (es) | Sales de r-ketamina y metodos de uso de las mismas. | |
| GEAP202516802A (en) | Protac chimeric compound, preparation method thereof and use thereof | |
| AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
| ZA202304541B (en) | Cdk inhibitors and their use as pharmaceuticals | |
| WO2025014877A3 (en) | Triazolo wrn inhibitors | |
| EA201992090A1 (ru) | ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| MX2023003576A (es) | Compuesto como inhibidor de la akt cinasa. | |
| WO2024254511A3 (en) | Wrn inhibitors | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| MY206262A (en) | Macrocyclic tyrosine kinase inhibitor and uses thereof | |
| MX2023014547A (es) | Proceso para la preparacion de inhibidores de familia de receptores tipo nod con dominio pirina 3 (nlrp3). | |
| EP4599892A3 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2025009374A (es) | Compuesto que contiene trifluorometilsulfonilo | |
| MX2024012014A (es) | Formas de sales de mesembrina | |
| MX2024014435A (es) | Compuestos heterociclicos y heteroarilo para el tratamiento de la enfermedad de huntington | |
| MX2025011564A (es) | Formas cristalinas de un compuesto para la degradacion dirigida del receptor de androgenos | |
| WO2024086789A3 (en) | Mutant pi3k-alpha inhibitors and their use as pharmaceuticals | |
| MX2023006193A (es) | Compuesto triciclico fusionado, metodo de preparacion y aplicacion del mismo en medicina. | |
| MX2025007158A (es) | Inhibidores de gmp?amp sintasa ciclica y sus usos | |
| EP4620940A3 (en) | Synthesis of (+)-cannabinoids and their therapeutic effects |